scholarly journals Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity

2019 ◽  
Vol 17 (1) ◽  
Author(s):  
Anca D. Askanase ◽  
R. Paola Daly ◽  
Miya Okado ◽  
Kayla Neville ◽  
Avery Pong ◽  
...  
2018 ◽  
Vol 28 (1) ◽  
pp. 253-265 ◽  
Author(s):  
Jennifer E. Flythe ◽  
Adeline Dorough ◽  
Julia H. Narendra ◽  
Rebecca L. Wingard ◽  
Lorien S. Dalrymple ◽  
...  

Author(s):  
Nicola Dalbeth

Although most tools used in gout research are generic, there are some important gout-specific instruments. New gout classification criteria were published in 2015. Outcome measure domains have been identified for both acute and chronic gout studies. A preliminary flare definition has been reported. Gout-specific, patient-reported outcome measure instruments allow assessment of gout disease activity and impact of tophi. Imaging scoring systems allow quantification of joint damage, inflammation, and urate burden in gout.


2017 ◽  
Vol 44 (5) ◽  
pp. 580-588 ◽  
Author(s):  
Ellen Lavoie Smith ◽  
Rylie Haupt ◽  
James Kelly ◽  
Deborah Lee ◽  
Grace Kanzawa-Lee ◽  
...  

2019 ◽  
Vol 3 (1) ◽  
Author(s):  
Roxanne M. Parslow ◽  
Alison Shaw ◽  
Kirstie L. Haywood ◽  
Esther Crawley

Abstract Background There is a lack of patient derived, child specific outcome measures to capture what health outcomes are important to children with Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). We developed a new Patient Reported Outcome Measure (PROM) for paediatric CFS/ME through qualitative research with children. This study aimed to pre-test the new measure through cognitive interviews with children with CFS/ME. Methods Cognitive interviews were undertaken in children’s homes or over Skype. The Three-Step Test-Interview (TSTI) method was used to assess the quality of the draft PROM with children with CFS/ME to identify problems with initial content and design and test modifications over subsequent interview rounds. Children were purposively sampled from a single specialist paediatric CFS/ME service in England. Results Twenty-four children and their parents took part. They felt the new measure captured issues relevant to their condition and preferred it to the generic measures they completed in clinical assessment. Changes were made to item content and phrasing, timeframe and response options and tested through three rounds of interviews. Conclusions Cognitive interviews identified problems with the draft PROM, enabling us to make changes and then confirm acceptability in children aged 11–18. Further cognitive interviews are required with children 8–10 years old to examine the acceptability and content validity and provide evidence for age related cut offs of the new PROM to meet FDA standards. This study demonstrates the content validity of the new measure as relevant and acceptable for children with CFS/ME. The next stage is to undertake a psychometric evaluation to support the reduction of items, confirm the structure of the PROM and provide evidence of the data quality, reliability and validity.


Sign in / Sign up

Export Citation Format

Share Document